Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 8
2020 13
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
From an On-site Program to a Mobile App for Prehabilitation and Rehabilitation for Robotic Radical Prostatectomy: Lessons Learned from 5 Years of Experience, the COVID-19 Outbreak, and Comparison with Nationwide Data.
Ploussard G, Kesch C, Calleris G, Buhas B, Salin A, Almeras C, Loison G, Lesourd M, Tollon C, Pradère B, Beauval JB. Ploussard G, et al. Among authors: lesourd m. Eur Urol Oncol. 2024 Apr;7(2):297-299. doi: 10.1016/j.euo.2023.10.007. Epub 2023 Oct 19. Eur Urol Oncol. 2024. PMID: 37865569 Free article.
Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy.
Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Soulié M, Loison G, Salin A, Tollon C, Malavaud B, Roumiguié M, Ploussard G. Manceau C, et al. Among authors: lesourd m. Eur Urol Open Sci. 2020 Aug 19;21:5-8. doi: 10.1016/j.euros.2020.07.003. eCollection 2020 Oct. Eur Urol Open Sci. 2020. PMID: 34337461 Free PMC article.
The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies.
Manceau C, Fromont-Hankard G, Beauval JB, Lesourd M, Almeras C, Bajeot AS, Gautier JR, Soulié M, Loison G, Salin A, Tollon C, Malavaud B, Roumiguié M, Ploussard G. Manceau C, et al. Among authors: lesourd m. World J Urol. 2021 Sep;39(9):3315-3321. doi: 10.1007/s00345-021-03631-7. Epub 2021 Feb 20. World J Urol. 2021. PMID: 33609168
Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experience.
Prudhomme T, Beauval JB, Lesourd M, Roumiguié M, Decaestecker K, Vignolini G, Campi R, Serni S, Territo A, Gausa L, Tugcu V, Sahin S, Alcaraz A, Musquera M, Stockle M, Janssen M, Fornara P, Mohammed N, Del Bello A, Kamar N, Sallusto F, Breda A, Doumerc N. Prudhomme T, et al. Among authors: lesourd m. World J Urol. 2021 Apr;39(4):1287-1298. doi: 10.1007/s00345-020-03309-6. Epub 2020 Jun 19. World J Urol. 2021. PMID: 32562044
Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions.
Manceau C, Roumiguié M, Lesourd M, Beauval JB, Almeras C, Aziza R, Gautier JR, Loison G, Meyrignac O, Salin A, Tollon C, Soulié M, Malavaud B, Ploussard G. Manceau C, et al. Among authors: lesourd m. Urol Oncol. 2020 Sep;38(9):734.e11-734.e17. doi: 10.1016/j.urolonc.2020.03.023. Epub 2020 Apr 17. Urol Oncol. 2020. PMID: 32312641
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.
Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G. Roumiguie M, et al. Among authors: lesourd m. Urol Oncol. 2020 May;38(5):386-392. doi: 10.1016/j.urolonc.2019.12.018. Epub 2020 Jan 13. Urol Oncol. 2020. PMID: 31948932
20 results